Joo Y. Song, M.D.

800-826-4673
Joo Song
Pathologist
Clinical Expertise
Hematopathology
Appointments
Associate Clinical Professor and Interim Vice Chair, Department of Pathology Chief, Division of Hematopathology

Joo Song, M.D., is an associate clinical professor at City of Hope's Department of Pathology. He is also a member of the Toni Stephenson Lymphoma Center at City of Hope.

Double board-certified in hematopathology and clinical/anatomic pathology, Dr. Song comes to City of Hope from the University of California Davis Medical Center where he was an assistant professor of pathology and associate medical director of outreach.

While at UC Davis, Dr. Song received the Department of Pathology Faculty Teaching Award, and was awarded a University of California Center for Health Quality and Innovation Fellowship.  He has received scholarships and awards from UCLA and George Washington University. Dr. Song earned his undergraduate degree (cum laude and with honors) in biology from the University of California Los Angeles. He received his medical degree from George Washington University, in Washington, DC, where he also completed his residency in anatomic and clinical pathology. He furthered his training with a clinical fellowship in a hematopathology at the National Institutes of Health, in Bethesda, Maryland, under the supervision of Elaine Jaffe, M.D.

Dr. Song is a member in good standing with various professional associations including the College of American Pathologists and the Society for Hematopathology. He has more than 60 peer-reviewed publications, abstracts and book chapters to his credit, has been principal investigator on externally funded research grants and has been invited to speak at numerous national conferences.
 

Location

Education & Experience

Board Certifications

  • American Board of Pathology (AP/CP)

  • American Board of Pathology (Hematology)

Degrees

  • 2005, M.D., George Washington University, Washington, DC

  • 1999, B.S., University of California Los Angeles (Biology), Cum Laude and College Honors

Fellowship

  • 2009-2011, Clinical Fellow, National Institutes of Health, Hematopathology, Bethesda, MD

Residency

  • 2005-2009, Anatomic and Clinical Pathology Residency, George Washington University, Washington, DC

Professional Experience

  • 2014-present, Associate Clinical Professor, Interim Chair, Division of Clinical Pathology, Department of Pathology, City of Hope, Duarte, CA

  • 2011-2014, Assistant Professor, University of California Davis Medical Center, Davis, CA

  • 2011-2014, Associate Medical Director of Outreach, University of California Davis Medical Center, Davis, CA

Research

Lab Members

The research interests of Joo Song, M.D., are focused on the genomics, prognostication, and classification of aggressive lymphomas such as Hodgkin lymphoma and diffuse large B cell lymphoma. He is also utilizing multi-immunofluorescence to study the tumor microenvironment in lymphomas to better understand the dynamics and interactions of the cellular subsets and correlate with response to therapies.

Awards & Memberships

Memberships

  • College of American Pathologists

  • United States and Canadian Academy of Pathology

  • American Society of Hematopathology

Publications

Complete list of published peer reviewed articles in MyBibliography.
  • Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES. Coexisting and clonally identical classical Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma. American Journal of Surgical Pathology. 2011; 35(5):767-772. PMID:21490448
  • Garcia-Herrera A, Song JY, Chuang S, Villamor N, Colomo L, Pittaluga S, Alvaro T, Rozman M, de Anda Gonzalez J, Arrunategui AM, Fernandez E, Gonzalvo E, Estrach T, Colomer D, Raffeld M, Gaulard P, Campo E, Jaffe ES, Martinez A. Non-hepatosplenic γδ Tcell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. American Journal of Surgical Pathology. 2011; 35(8):1214- 1225. PMID:21753698
  • Song JY, Strom TS, Raffeld M, Pittaluga S, Jaffe ES. Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20. Journal of Clinical Oncology. 2011; 29(32):789-791. PMID:21990402
  • Eberle FC, Song JY*, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. American Journal of Surgical Pathology. 2012; 36(8):716-725. *Cofirst author. PMID:22367293
  • Venkataraman G, Song JY, Traverse-Glehen A, Eberle F, Hanson J, Tzankov A, Dirnhofer S, Heinze G, Kohl M, Raffeld M, Pittaluga S, Jaffe ES. Aberrant T-Cell Antigen Expression in Classical Hodgkin Lymphoma is Associated with Decreased Event-Free Survival and Overall Survival. Blood. 2013;121(10):1795-1804. PMID:23305738
  • Mamessier E, Song JY, Eberle FC, Pack S, Drevet C, Chetaille B, Abdullaev Z, Birnbaum D, Chaffanet M, Pittaluga S, Roulland S, Chott A, Jaffe ES, Nadel B. Early lesions of follicular lymphoma: a genetic perspective. Haematologica. 2014; 99(3):481-488. PMID:24162788
  • Song JY, Pittaluga S, Dunleavy K, Grant N, White T, Jiang L, Davies-Hill T, Raffeld M, Wilson WH, Jaffe ES. Lymphomatoid granulomatosis, a single institute experience: pathologic findings and clinical correlations. American Journal of Surgical Pathology. 2015;39(2):141-156. PMID:25321327
  • Song JY, Venkataraman G, Fedoriw Y, Alikhan MB, Kim YS, Weisenburger DD, Murata-Collins JL, Liu X, Duffield AS. Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults. Leukemia and Lymphoma. 2015:8;1-6. PMID:26450341
  • Alikhan M, Song JY*, Sohani AR, Moroch J, Plonquet A, Duffield AS, Borowitz MJ, Jiang L, Bueso-Ramos C, Inamdar K, Menon MP, Gurbuxani S, Chan E, Smith SM, Nicolae A, Jaffe ES, Gaulard P, Venkataraman G. Peripheral T-cell lymphomas of follicular helper T-cell derivation frequently display an aberrant CD3-/dimCD4+ population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Modern Pathology. 2016;29:1173-82. *Co-first author. PMID: 27312067.
  • Song JY, Song L, Herrera AF, Venkataraman G, Murata-Collins JL, Bedell V, Chen YY, Kim YS, Tadros R, Nathwani BN, Weisenburger DD, Feldman AL. Cyclin D1 expression in Peripheral T-cell lymphomas. Modern Pathology. 2016;29(11):1306-1312. PMID: 27469326.
  • Song JY, Egan C, Bouska AC, Zhang W, Gong Q, Venkataraman G, Herrera AF, Chen L, Ottesen R, Niland JC, Bedell V, Valle-Catuna M, Murata-Collins J, Weisenburger DD, Iqbal J, Jaffe ES, Chan WC. Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma. Leukemia. 2020. PMID: 32054999.
  • Persky DO, Li H, Stephens DM, Park SI, Bartlett NL, Swinnen LJ, Barr PM, Winegarden JD, 3rd, Constine LS, Fitzgerald TJ, Leonard JP, Kahl BS, LeBlanc ML, Song JY, Fisher RI, Rimsza LM, Smith SM, Miller TP, Friedberg JW. Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001. J Clin Oncol 2020;38:3003-11. PMID: 32658627.
  • Persky DO, Li H, Stephens DM, Park SI, Bartlett NL, Swinnen LJ, Barr PM, Winegarden JD, 3rd, Constine LS, Fitzgerald TJ, Leonard JP, Kahl BS, LeBlanc ML, Song JY, Fisher RI, Rimsza LM, Smith SM, Miller TP, Friedberg JW. Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001. J Clin Oncol 2020;38:3003-11. PMID: 32658627.
  • Nguyen H, Perry A, Skrabek P, Nasr M, Herrera AF, Bedell V, Murata-Collins J, Pillai R, Xu M, Chen L, Chan WC, Weisenburger DD, Scott DW, Song JY. Validation of the double-hit gene expression signature (DLBCL90) in an independent cohort of patients with diffuse large B-cell lymphoma of germinal center origin. J Mol Diagnostics 2021;23(5):658-64. PMID: 33636392.
  • Ramis-Zaldivar JE, Gonzalez-Farre B, Nicolae A, Pack S, Clot G, Nadeu F, Mottok A, Horn H, Song JY, Fu K, Wright G, Gascoyne RD, Chan WC, Scott DW, Feldman AL, Valera A, Enjuanes A, Braziel RM, Smeland EB, Staudt LM, Rosenwald A, Rimsza LM, Ott G, Jaffe ES, Salaverria I, Campo E. MAP-kinase and JAK-STAT pathways dysregulation in plasmablastic lymphoma. Haematologica. 2021. PMID: 33951889.
  • Ramis-Zaldivar JE, Gonzalez-Farre B, Nicolae A, Pack S, Clot G, Nadeu F, Mottok A, Horn H, Song JY, Fu K, Wright G, Gascoyne RD, Chan WC, Scott DW, Feldman AL, Valera A, Enjuanes A, Braziel RM, Smeland EB, Staudt LM, Rosenwald A, Rimsza LM, Ott G, Jaffe ES, Salaverria I, Campo E. MAP-kinase and JAK-STAT pathways dysregulation in plasmablastic lymphoma. Haematologica. 2021. PMID: 33951889.